Related Experiment Video
Updated: Jul 30, 2026

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
Levels of cefuroxime in bronchial secretion
Cefuroxime levels in bronchial secretions were sufficient to combat chest pathogens. Higher doses of this antibiotic resulted in better penetration into the lungs, indicating a dose-dependent effect for treating respiratory infections.
Area of Science:
- Pharmacology
- Respiratory Medicine
- Infectious Diseases
Background:
- Bronchoscopy is a key diagnostic tool for respiratory conditions.
- Understanding antibiotic penetration into bronchial secretions is crucial for effective treatment.
- Cefuroxime is a commonly used antibiotic for bacterial infections.
Purpose of the Study:
- To measure cefuroxime levels in bronchial secretions.
- To evaluate the relationship between cefuroxime dosage and its penetration into the lungs.
- To determine if achieved levels exceed minimum inhibitory concentrations (MICs) for common chest pathogens.
Main Methods:
- 49 patients undergoing diagnostic bronchoscopy were enrolled.
- Patients received intravenous cefuroxime in four different dosage regimens (750 mg or 1.5 g, single or multiple doses).
- Bronchial secretions were sampled approximately one hour after cefuroxime administration.
Main Results:
- Cefuroxime levels in bronchial secretions were adequate across all tested dosages.
- Achieved cefuroxime concentrations surpassed MIC values for major respiratory pathogens.
- A clear dose-dependent relationship was observed for cefuroxime penetration into bronchial secretions.
Conclusions:
- Cefuroxime effectively penetrates bronchial secretions at the studied dosages.
- The antibiotic's efficacy against chest pathogens is supported by achieved secretion levels.
- Treatment strategies involving cefuroxime should consider dose optimization for enhanced lung penetration.
More Related Videos
11:54Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
Published on: January 21, 2018
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
Related Concept Videos
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
Chest Physiotherapy
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Microbiota of the Respiratory Tract